空心胶囊市场机会、成长动力、产业趋势分析与预测 2024 - 2032

2023 年全球空心胶囊市场价值为31 亿美元，预计2024 年至2032 年复合年增长率为6.3%。保健品的需求不断增长，很大程度上是由于人们健康意识的增强和健康意识的增强。此外，製药业正在转向胶囊製剂，因为胶囊製剂易于吞嚥，能够掩盖味道，并且具有控释递送的潜力，这使得它们成为比传统片剂更受欢迎的选择。

市场主要分为两大类：明胶胶囊和非明胶胶囊。明胶细分市场占据主导份额，预计到2032 年将以6.5% 的复合年增长率增长。保持产品稳定性。这些胶囊还具有卓越的生物利用度，确保活性成分更好地吸收。源自各种动物来源的明胶具有多功能性，使製造商能够定製配方，使其适合各种消费者的喜好和需求。

在应用方面，市场分为不同的治疗领域，包括维生素和膳食补充剂、抗生素、抗发炎药物、心血管治疗等。维生素和膳食补充剂细分市场是 2023 年的主要贡献者，产生了可观的收入。随着注重健康的消费者越来越多地寻求方便有效的方法来增强营养摄入，对胶囊的需求激增。胶囊提供了一种理想的方法来传递这些补充剂，确保有效吸收和生物利用度。人口老化的不断增长和预防性医疗保健的广泛采用进一步推动了这一领域的需求。

美国在北美空心胶囊市场占据关键地位，占相当大的份额。该国的市场主导地位得到了强大的製药和营养保健品行业的支持，同时消费者对膳食补充剂的需求不断增长，以及个人化医疗的趋势。美国也受益于尖端的製造技术和严格的监管标准，确保生产出符合消费者期望的高品质胶囊。此外，胶囊配方的创新以及素食和明胶选择的日益普及也进一步促进了市场的扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 对营养保健品和膳食补充剂的需求不断增加
    • 製药业的成长
    • 偏好胶囊剂型
  • 产业陷阱与挑战
    • 品质控制和一致性
    • 生产成本高
• 成长潜力分析
• 监管环境
• 技术景观
• 未来市场趋势
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 明胶
  • 猪明胶
  • 牛源性
  • 骨粉
  • 其他明胶胶囊类型
• 非明胶
  • 羟丙基甲基纤维素（HPMC）
  • 普鲁兰多醣和淀粉

第 6 章：市场估计与预测：按功能划分，2021 - 2032 年

• 主要趋势
• 立即发布
• 持续释放
• 延迟发布

第 7 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 抗生素和抗菌药物
• 维生素和膳食补充剂
• 抗酸剂和抗胀气製剂
• 抗贫血製剂
• 抗发炎药
• 心血管治疗药物
• 咳嗽和感冒药物
• 其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 製药
• 营养保健品
• 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：公司简介

• ACG
• BioCaps Enterprise
• Bright Pharma Caps
• CapsCanada Corporation
• Chemcaps Limited
• Fortcaps Healthcare
• HealthCaps India
• Lonza Group
• Medi-Caps
• Nectar Lifesciences
• Qualicaps
• Shanxi JC Biological Technology
• Suheung
• Sunil Healthcare

The Global Empty Capsules Market, valued at USD 3.1 billion in 2023, is projected to grow at a CAGR of 6.3% from 2024 to 2032. This growth is driven by the rising demand for dietary supplements and nutraceuticals, largely fueled by greater health consciousness and the increasing preference for preventive healthcare. Furthermore, the pharmaceutical industry is shifting toward capsule formulations due to their ease of swallowing, ability to mask the taste, and potential for controlled-release delivery, which makes them a preferred choice over traditional tablets.

The market is primarily divided into two categories: gelatin and non-gelatin capsules. The gelatin segment holds a dominant share and is anticipated to grow at a CAGR of 6.5% through 2032. Gelatin capsules are widely used in both the pharmaceutical and dietary supplement industries, owing to their ability to protect sensitive ingredients from moisture and oxygen, thus maintaining product stability. These capsules also offer superior bioavailability, ensuring better absorption of active ingredients. The versatility of gelatin, derived from various animal sources, allows manufacturers to customize formulations, making them suitable for a wide range of consumer preferences and needs.

In terms of applications, the market is segmented into various therapeutic areas, including vitamins and dietary supplements, antibiotics, anti-inflammatory drugs, cardiovascular therapies, and others. The vitamins and dietary supplements segment was the leading contributor in 2023, generating significant revenue. As health-conscious consumers increasingly seek convenient and efficient ways to enhance their nutritional intake, the demand for capsules has surged. Capsules provide an ideal method for delivering these supplements, ensuring effective absorption and bioavailability. The growing aging population and the widespread adoption of preventive healthcare are further boosting the demand for this segment.

The U.S. holds a key position in the North American empty capsules market, accounting for a substantial share. The country's market dominance is supported by a strong pharmaceutical and nutraceutical sector, alongside increasing consumer demand for dietary supplements and the trend toward personalized medicine. The U.S. also benefits from cutting-edge manufacturing technologies and rigorous regulatory standards, which ensure the production of high-quality capsules that meet consumer expectations. Additionally, innovations in capsule formulations and the growing popularity of both vegetarian and gelatin options are further contributing to market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for nutraceuticals and dietary supplements
    • 3.2.1.2 Growth of pharmaceutical industry
    • 3.2.1.3 Preference for capsule-based dosage forms
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Quality control and consistency
    • 3.2.2.2 High production costs
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Gelatin
  • 5.2.1 Porcine gelatin
  • 5.2.2 Bovine derived
  • 5.2.3 Bone meal
  • 5.2.4 Other gelatin capsule types
• 5.3 Non-gelatin
  • 5.3.1 Hydroxypropyl methylcellulose (HPMC)
  • 5.3.2 Pullulan & starch

Chapter 6 Market Estimates and Forecast, By Functionality, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Immediate release
• 6.3 Sustained release
• 6.4 Delayed release

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Antibiotic and antibacterial drugs
• 7.3 Vitamins and dietary supplements
• 7.4 Antacid and anti-flatulent preparations
• 7.5 Anti-anemic preparations
• 7.6 Anti-inflammatory drugs
• 7.7 Cardiovascular therapy drugs
• 7.8 Cough and cold drugs
• 7.9 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical
• 8.3 Nutraceutical
• 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ACG
• 10.2 BioCaps Enterprise
• 10.3 Bright Pharma Caps
• 10.4 CapsCanada Corporation
• 10.5 Chemcaps Limited
• 10.6 Fortcaps Healthcare
• 10.7 HealthCaps India
• 10.8 Lonza Group
• 10.9 Medi-Caps
• 10.10 Nectar Lifesciences
• 10.11 Qualicaps
• 10.12 Shanxi JC Biological Technology
• 10.13 Suheung
• 10.14 Sunil Healthcare